Stryker Financial Statements From 2010 to 2024
| SYK Stock | EUR 371.20 8.40 2.32% |
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as , as well as many indicators such as . Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
Stryker |
Stryker Company Return On Equity Analysis
Stryker's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Stryker Return On Equity | 0.15 |
Most of Stryker's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Stryker has a Return On Equity of 0.1498. This is 100.62% lower than that of the Healthcare sector and 101.72% lower than that of the Medical Devices industry. The return on equity for all Germany stocks is 148.32% lower than that of the firm.
Stryker Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stryker's current stock value. Our valuation model uses many indicators to compare Stryker value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stryker competition to find correlations between indicators driving Stryker's intrinsic value. More Info.Stryker is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Stryker is roughly 2.42 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stryker's earnings, one of the primary drivers of an investment's value.About Stryker Financial Statements
Stryker stakeholders use historical fundamental indicators, such as Stryker's revenue or net income, to determine how well the company is positioned to perform in the future. Although Stryker investors may analyze each financial statement separately, they are all interrelated. For example, changes in Stryker's assets and liabilities are reflected in the revenues and expenses on Stryker's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Stryker. Please read more on our technical analysis and fundamental analysis pages.
Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. STRYKER CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 36000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Stryker Stock
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out the analysis of Stryker Correlation against competitors. For more detail on how to invest in Stryker Stock please use our How to Invest in Stryker guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.